ARTV (Artiva Biotherapeutics) Total Liabilities : $22.94 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Artiva Biotherapeutics Total Liabilities?

Artiva Biotherapeutics's Total Liabilities for the quarter that ended in Dec. 2024 was $22.94 Mil.

Artiva Biotherapeutics's quarterly Total Liabilities declined from Jun. 2024 ($267.01 Mil) to Sep. 2024 ($24.60 Mil) and declined from Sep. 2024 ($24.60 Mil) to Dec. 2024 ($22.94 Mil).

Artiva Biotherapeutics's annual Total Liabilities declined from Dec. 2022 ($273.75 Mil) to Dec. 2023 ($267.13 Mil) and declined from Dec. 2023 ($267.13 Mil) to Dec. 2024 ($22.94 Mil).

Artiva Biotherapeutics Total Liabilities Historical Data

The historical data trend for Artiva Biotherapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artiva Biotherapeutics Total Liabilities Chart

Artiva Biotherapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

50.80

258.78

273.75

267.13

22.94

Artiva Biotherapeutics Quarterly Data
	Dec19	Dec20	Mar21	Sep21	Dec21	Mar22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial										267.13	264.83	267.01	24.60	22.94

Artiva Biotherapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Artiva Biotherapeutics's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	12.253	+	(10.614	+	0.073
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	22.94

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	209.581	-	186.641
	=	22.94

Artiva Biotherapeutics's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	12.253	+	(10.614	+	0.073
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	22.94

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	209.581	-	186.641
	=	22.94

Artiva Biotherapeutics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Artiva Biotherapeutics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Artiva Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Artiva Biotherapeutics Inc (NAS:ARTV) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

5505 Morehouse Drive, Suite 100, San Diego, CA, USA, 92121

Website

https://www.artivabio.com

Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials.